Covid vaccine patent landscape heats up as Pfizer's partner sues Arbutus and Genevant
The patent landscape around the two top Covid-19 vaccines is getting more complex and contested by the day.
Most recently, Canadian biotech Acuitas sued Arbutus …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
